UB Paderborn / Katalog / Suche / in CDI

Collagen VI as a driver and disease biomarker in human fibrosis

The FEBS journal, 2022-07, Vol.289 (13), p.3603-3629

2022

Volltextzugriff (PDF)

Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR -Mutant Chronic Myeloproliferative Neoplasms

Frontiers in oncology, 2021-02, Vol.11, p.637420-637420

2021

Volltextzugriff (PDF)

Generation of cancer vaccine immunogens derived from major histocompatibility complex (MHC) class I molecules using variable epitope libraries

Immunology letters, 2018-12, Vol.204, p.47-54

2018

Volltextzugriff (PDF)

Robust Iterative Stimulation with Self-Antigens Overcomes CD8+ T Cell Tolerance to Self- and Tumor Antigens

Cell reports (Cambridge), 2019-09, Vol.28 (12), p.3092-3104.e5

2019

Volltextzugriff (PDF)

The Role of β Cell Stress and Neo-Epitopes in the Immunopathology of Type 1 Diabetes

Frontiers in endocrinology (Lausanne), 2021-02, Vol.11, p.624590-624590

2021

Volltextzugriff (PDF)

Non-Genetically Encoded Epitopes Are Relevant Targets in Autoimmune Diabetes

Biomedicines, 2021-02, Vol.9 (2), p.202

2021

Volltextzugriff (PDF)

Immune-resistant mechanisms in cancer immunotherapy

International journal of clinical oncology, 2020-05, Vol.25 (5), p.810-817

2020

Volltextzugriff (PDF)

Cancer vaccines: Targeting KRAS-driven cancers

Expert review of vaccines, 2020-02, Vol.19 (2), p.163-173

2020

Volltextzugriff (PDF)

Functional and Structural Characterization of a Novel HLA-DRB104:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis

Frontiers in immunology, 2016-11, Vol.7, p.494-494

2016

Volltextzugriff (PDF)

Neo-Antigen mRNA Vaccines

Vaccines (Basel), 2020-12, Vol.8 (4), p.776

2020

Volltextzugriff (PDF)

Prospects for a personalized peptide vaccine against lung cancer

Expert review of vaccines, 2019-07, Vol.18 (7), p.703-709

2019

Volltextzugriff (PDF)

Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes

Frontiers in endocrinology (Lausanne), 2017-09, Vol.8, p.262-262

2017

Volltextzugriff (PDF)

β cell ER stress and the implications for immunogenicity in type 1 diabetes

Frontiers in cell and developmental biology, 2015-10, Vol.3, p.67-67

2015

Volltextzugriff (PDF)

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design

BMC genomics, 2018-08, Vol.19 (1), p.582-582, Article 582

2018

Volltextzugriff (PDF)

The HLA Ligandome Comprises a Limited Repertoire of O-GlcNAcylated Antigens Preferentially Associated With HLA-B07:02

Frontiers in immunology, 2021-12, Vol.12, p.796584-796584

2021

Volltextzugriff (PDF)

Genome variation across cancers scales with tissue stiffness – An invasion-mutation mechanism and implications for immune cell infiltration

Current opinion in systems biology, 2017-04, Vol.2, p.103-114

2017

Volltextzugriff (PDF)

Differential mutation spectrum and immune landscape in African Americans versus Whites: A possible determinant to health disparity in head and neck cancer

Cancer letters, 2020-11, Vol.492, p.44-53

2020

Volltextzugriff (PDF)

Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer

Cancer Immunology, Immunotherapy, 2020-02, Vol.69 (2), p.315-324

2020

Volltextzugriff (PDF)

Exploiting Autophagy-Dependent Neoantigen Presentation in Tumor Microenvironment

Genes, 2023-02, Vol.14 (2), p.474

2023

Volltextzugriff (PDF)

Translocations and Gene Fusions in Sinonasal Malignancies

Current oncology reports, 2023-04, Vol.25 (4), p.269-278

2023

Volltextzugriff (PDF)

A Novel DNA Vaccine Platform Enhances Neo-antigen-like T Cell Responses against WT1 to Break Tolerance and Induce Anti-tumor Immunity

Molecular therapy, 2017-04, Vol.25 (4), p.976-988

2017

Volltextzugriff (PDF)

Topology and adenocarcinoma cell localization dataset on the labyrinthin diapeutic biomarker

BMC research notes, 2023-07, Vol.16 (1), p.139-139, Article 139

2023

Volltextzugriff (PDF)

Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome

Oncoimmunology, 2020-01, Vol.9 (1), p.1684714

2020

Volltextzugriff (PDF)

Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime

Frontiers in immunology, 2020-08, Vol.11, p.1996-1996

2020

Volltextzugriff (PDF)

Combination Immunotherapy for Type 1 Diabetes

Current diabetes reports, 2017-07, Vol.17 (7), p.50-50, Article 50

2017

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Collagen VI as a driver and disease biomarker in human fibrosis

Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR -Mutant Chronic Myeloproliferative Neoplasms

Generation of cancer vaccine immunogens derived from major histocompatibility complex (MHC) class I molecules using variable epitope libraries

Robust Iterative Stimulation with Self-Antigens Overcomes CD8+ T Cell Tolerance to Self- and Tumor Antigens

The Role of β Cell Stress and Neo-Epitopes in the Immunopathology of Type 1 Diabetes

Non-Genetically Encoded Epitopes Are Relevant Targets in Autoimmune Diabetes

Immune-resistant mechanisms in cancer immunotherapy

Cancer vaccines: Targeting KRAS-driven cancers

Functional and Structural Characterization of a Novel HLA-DRB104:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis

Neo-Antigen mRNA Vaccines

Prospects for a personalized peptide vaccine against lung cancer

Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes

β cell ER stress and the implications for immunogenicity in type 1 diabetes

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design

The HLA Ligandome Comprises a Limited Repertoire of O-GlcNAcylated Antigens Preferentially Associated With HLA-B07:02

Genome variation across cancers scales with tissue stiffness – An invasion-mutation mechanism and implications for immune cell infiltration

Differential mutation spectrum and immune landscape in African Americans versus Whites: A possible determinant to health disparity in head and neck cancer

Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer

Exploiting Autophagy-Dependent Neoantigen Presentation in Tumor Microenvironment

Translocations and Gene Fusions in Sinonasal Malignancies

A Novel DNA Vaccine Platform Enhances Neo-antigen-like T Cell Responses against WT1 to Break Tolerance and Induce Anti-tumor Immunity

Topology and adenocarcinoma cell localization dataset on the labyrinthin diapeutic biomarker

Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome

Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime

Combination Immunotherapy for Type 1 Diabetes

Suchergebnisse filtern